Dimension Therapeutics, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3
Dimension Therapeutics, Inc. reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 of $0 for the 6-month period ending 2016-06-30, per its 10-Q filed 2016-08-11.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 · last filed 2016-08-11
- Dimension Therapeutics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset transfers into level 3 for the quarter ending 2016-06-30 was $0.00.
- Dimension Therapeutics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset transfers into level 3 for the quarter ending 2016-03-31 was $0.00.
- Dimension Therapeutics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset transfers into level 3 for fiscal 2014 was $0.00.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 12 month |
|---|---|---|---|
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $0.00 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-12 | ||
| 2015-12-31 | $0.00 10-Q · filed 2016-08-11 | ||
| 2014-12-31 | $0.00 10-K · filed 2016-03-24 |